PCP
EPZM

Proficio Capital Partners’s Epizyme, Inc EPZM Stock Holding History

Proficio Capital Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-440
Closed -$6K – 1747
2019
Q2 		$6K Hold
440
– – ﹤0.01% 1173
2019
Q1 		$5K Buy
+440
New +$4.92K ﹤0.01% 1134

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Proficio Capital Partners's EPZM Position: Q3 2019 in Review

Proficio Capital Partners sold out of Epizyme, Inc (EPZM) in Q3 2019, closing a stake of 440 shares — an estimated $6K sold.

Proficio Capital Partners first reported a position in EPZM in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q2 2019. 115 funds tracked by Wall St. Rank hold EPZM as of Q3 2019.

  • Proficio Capital Partners reported no remaining Epizyme, Inc position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 440 Epizyme, Inc shares in Q3 2019, an estimated $6K.
  • Proficio Capital Partners first reported a position in Epizyme, Inc in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Epizyme, Inc position peaked at $6K in Q2 2019.
  • 115 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.